Global Conjunctivitis Treatment Market, By Type (Allergic Conjunctivitis, Infectious Conjunctivitis, Chemical Conjunctivitis), Therapy Type (Antibiotic Therapy and Eye Warming Therapy), Drugs (Antibiotics, Ophthalmic Steroids, Non-Steroidal Anti-Inflammatory Drugs, Antihistamines and Others), Route of Administration (Oral and Topical), End- users (Hospitals, Homecare, Specialty Clinics, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Conjunctivitis Treatment Market
Conjunctivitis treatment market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 3.90% in the above mentioned forecast period and expected to reach the USD of 21.46 billion by 2028.
Conjunctiva is defined as a transparent tissue layer which covers the inner surface of the eyelid. When the infection develops on this tissue then it covers the white part of the eye and result in the red or pink colour of eye. Therefore, it is also called pink eye. This is an ophthalmic infection that causes inflammation of the eye and called conjunctivitis. Its causes are classified into infectious and non-infectious causes. Bacterial and viral are involved in the infectious cause and allergic and inflammation of the immune-mediated disease are included in the non-infectious cause. The types of this condition depends on the severity of disease and include acute conjunctivitis, hyper acute and chronic. This helps the medical professionals to take rapid decisions about the treatment.
Rise in the prevalence of conjunctivitis along with the emergence of drugs used in the treatment are the major factors influencing the growth of the market. Moreover, presence of outdoors as well as indoor allergens and exposure to certain toxins and changes in the environment are the factors that will expand the conjunctivitis treatment market.
Emerging new market and ongoing clinical trials will provide beneficial opportunities for the conjunctivitis treatment market in the forecast period of 2021-2028.
However, unavailability as well as less affordability of the effective treatment, patent expiry from many companies and introduction of generic drugs are the factors that will hinder the market growth. Inadequate knowledge about the disease and its treatment will challenge the conjunctivitis treatment market in the forecast period mentioned above.
This conjunctivitis treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the conjunctivitis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Conjunctivitis Treatment Market Scope and Market Size
The conjunctivitis treatment market is segmented on the basis of type, therapy type, drugs, route of administration and end-users. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the conjunctivitis treatment market is segmented into allergic conjunctivitis, infectious conjunctivitis and chemical conjunctivitis.
- On the basis of therapy type, the conjunctivitis treatment market is segmented into antibiotic therapy and eye warming therapy.
- On the basis of drugs, the conjunctivitis treatment market is segmented into antibiotics, ophthalmic steroids, non-steroidal anti-inflammatory drugs, antihistamines and others. Antibiotics have been further sub-segmented into gatifloxacin, moxifloxacin, tobramycin and others. Ophthalmic steroids have been further sub-segmented into dexamethasone. Non-steroidal anti-inflammatory drugs have been further sub-segmented into diclofenac. Antihistamines have been further sub-segmented into lodoxamide, olopatadine hydrochloride and cetirizine.
- On the basis of route of administration, the conjunctivitis treatment market is segmented into oral and topical.
- The conjunctivitis treatment market is also segmented on the basis of end-users into hospitals, homecare, specialty clinics and others.
Conjunctivitis Treatment Market Country Level Analysis
Conjunctivitis treatment market is analyzed and market size information is provided by the country, type, therapy type, drugs, route of administration and end-users as referenced above.
The countries covered in the conjunctivitis treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the conjunctivitis treatment market due to the presence of major key players, rise in the prevalence of eye disorders and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the surge in the investment for healthcare sector, growing awareness and increase in the disposable income.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Conjunctivitis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Conjunctivitis Treatment Market Share Analysis
Conjunctivitis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to conjunctivitis treatment market research.
The major players covered in the conjunctivitis treatment market report are Allergan, Lupin, Nicox, Eyevance Pharmaceuticals LLC, ALLERGAN, Novartis AG, Aurobindo Pharma, Cipla Inc, Mylan N.V, WOCKHARDT, Akron Incorporated, USV Private Limited, Teva Pharmaceutical Industries Ltd, Dr. Reddy’s Laboratories Ltd, Mankind Pharma, Micro Labs Ltd., and Bausch Health Companies Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-